# Nuclide record prosper (trial). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/trials/prosper/>
  a schema:MedicalTrial ;
  nuclide:kind "trial" ;
  schema:identifier "prosper", "NCT02003924" ;
  schema:name "PROSPER"@en ;
  schema:description "PROSPER showed that enzalutamide delayed the appearance of metastases by about two years, and later helped men live longer, when given at the point where prostate cancer is rising on hormone therapy but has not yet spread on scans."@en ;
  schema:url <https://nuclide.cc/trials/prosper/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02003924> ;
  nuclide:status "positive" ;
  nuclide:tag "subtype-trials" ;
  nuclide:phase "3" ;
  nuclide:indications <https://nuclide.cc/indications/prostate-nmcrpc/>, <https://nuclide.cc/indications/prostate/> ;
  nuclide:drugs <https://nuclide.cc/drugs/enzalutamide/> ;
  nuclide:companies <https://nuclide.cc/companies/pfizer/> .